Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-08 11:07 am Sale | 2023-04-30 | 13G | Apollo Endosurgery, Inc. APEN | CITIGROUP INC C | 0 0.000% | -2,485,457 (Position Closed) | Filing History |
| 2023-04-04 8:50 pm Sale | 2023-04-04 | 13D | Apollo Endosurgery, Inc. APEN | CPMG Inc | 0 0.000% | -6,183,603 (Position Closed) | Filing History |
| 2023-04-04 4:00 pm Purchase | 2023-03-31 | 13G | Apollo Endosurgery, Inc. APEN | Hedgehog Capital LLC | 3,279,636 5.600% | 3,279,636 (New Position) | Filing History |
| 2023-02-14 5:11 pm Purchase | 2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Nantahala Capital Management, LLC | 4,056,627 9.900% | 84,985 (+2.14%) | Filing History |
| 2023-02-14 08:14 am Sale | 2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Soleus Capital Master Fund, L.P. | 0 0.000% | -2,295,100 (Position Closed) | Filing History |
| 2023-02-13 3:24 pm Sale | 2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Laurence W. Lytton | 3,403,180 6.700% | -286,740 (-7.77%) | Filing History |
| 2023-02-13 10:35 am Purchase | 2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Stonepine Capital Management, LLC | 4,351,088 9.000% | 1,695,959 (+63.87%) | Filing History |
| 2023-02-10 12:11 pm Purchase | 2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN | CITIGROUP INC C | 2,485,457 6.000% | 2,485,457 (New Position) | Filing History |
| 2023-02-08 4:10 pm Sale | 2023-02-02 | 13G | Apollo Endosurgery, Inc. APEN | Gagnon Securities LLC | 717,490 1.700% | -3,013,401 (-80.77%) | Filing History |
| 2023-02-06 4:05 pm Purchase | 2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Gagnon Securities LLC | 3,730,891 9.000% | 342,812 (+10.12%) | Filing History |
| 2022-12-30 5:16 pm Purchase | 2022-12-28 | 13D | Apollo Endosurgery, Inc. APEN | CPMG Inc | 6,183,603 13.000% | 106,206 (+1.75%) | Filing History |
| 2022-02-15 4:57 pm Purchase | 2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Laurence W. Lytton | 3,689,920 9.300% | 1,041,770 (+39.34%) | Filing History |
| 2022-02-14 08:03 am Purchase | 2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Nantahala Capital Management, LLC | 3,971,642 9.900% | 1,346,670 (+51.30%) | Filing History |
| 2022-02-11 7:03 pm Purchase | 2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Stonepine Capital Management, LLC | 2,655,129 6.500% | 51,649 (+1.98%) | Filing History |
| 2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Soleus Capital Master Fund, L.P. | 2,295,100 5.800% | 209,603 (+10.05%) | Filing History |
| 2022-02-03 4:21 pm Purchase | 2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Gagnon Securities LLC | 3,388,079 8.600% | 389,601 (+12.99%) | Filing History |
| 2021-12-20 5:01 pm Purchase | 2021-12-14 | 13G | Apollo Endosurgery, Inc. APEN | Soleus Capital Master Fund, L.P. | 2,085,497 5.300% | 2,085,497 (New Position) | Filing History |
| 2021-10-19 5:22 pm Purchase | 2021-10-15 | 13D | Apollo Endosurgery, Inc. APEN | CPMG Inc | 6,077,397 15.000% | 938,892 (+18.27%) | Filing History |
| 2021-03-09 3:50 pm Sale | 2020-10-30 | 13D | Apollo Endosurgery, Inc. APEN | PTV SCIENCES II L P | 1,355,858 5.200% | -1,946,816 (-58.95%) | Filing History |
| 2021-02-16 11:22 am Sale | 2020-12-31 | 13G | Apollo Endosurgery, Inc. APEN | Laurence W. Lytton | 2,648,150 9.990% | -17,782 (-0.67%) | Filing History |